Brain-Health app and coaching trial aims to prevent dementia in At-Risk seniors
NCT ID NCT07376135
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether a personalized lifestyle program combining workshops, remote coaching, and a smartphone app can help adults aged 55-75 at risk for dementia adopt healthier habits. 300 participants will either receive tailored guidance or standard advice. The main goal is to see if the program is practical and engaging, not yet to prove it prevents cognitive decline.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
hybrid multidomain lifestyle intervention (personalized coaching, workshops, app, smartwatch)
What this could lead to
If successful, this could point toward an effective, scalable way to reduce dementia risk in older adults through lifestyle changes.
What could go wrong
This is a small pilot trial focused on feasibility, not proof of effectiveness. The results may not generalize, and long-term adherence to lifestyle changes is challenging.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT (MCI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical University of Innsbruck
Graz, Styria, 8010, Austria
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Medical University of Innsbruck
Innsbruck, Tyrol, 6020, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Medical University of Vienna
Vienna, Austria
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact